AWV Practice Redesign Toolkit for Preventive Health Services
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving preventive health services rather than changing medication use.
What data supports the effectiveness of the treatment AWV Practice Redesign Toolkit for Preventive Health Services?
Research shows that redesigning healthcare practices, like the Plummer Project at Mayo Clinic, can improve patient care quality and safety by standardizing processes and enhancing efficiency. Additionally, interventions to increase the use of Medicare Annual Wellness Visits can help in planning personalized preventive health services, suggesting that practice redesign can be effective in improving preventive care.12345
How is the Medicare AWV Practice Redesign Toolkit different from other treatments?
The Medicare AWV Practice Redesign Toolkit is unique because it focuses on preventive health services through annual wellness visits, which are free for Medicare recipients and emphasize health maintenance, risk assessment, and prevention of illness. Unlike other treatments, it incorporates the 4Ms of age-friendly healthcare—what matters, medication, mentation, and mobility—into the visit, and can be delivered by registered nurses or pharmacists, making it more accessible and tailored to individual needs.13678
What is the purpose of this trial?
The goal of this study is to improve the use of preventive health services by implementing the AWV Practice Redesign Toolkit to stimulate AWV visit use in diverse practices across the United States. This is a stepped wedge cluster randomized controlled trial. The intervention will be implemented in a total of 16 small-to-mid-size primary care practices (at the practice level) with clinicians and staff. Eight practices will participate in the main clinical trial, and 8 in a replication study. The main clinical trial (with community-based practices) and replication study (with Federally Qualified Health Center practices) will be conducted simultaneously. Electronic health record (EHR) data extractions will be used to collect outcomes in a population cohort of patients. Semi-structured interviews will be conducted with clinicians/staff and patients to assess intervention implementation. The investigators hypothesize that the toolkit implementation will increase AWV visit use and consequently, use of preventive health services.
Research Team
Derjung M Tarn, MD,PhD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for individuals aged 50 or older with Medicare insurance who have visited one of the participating primary care practices in the past year and are not deceased. It aims to engage both patients and healthcare staff.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Control Period
Initial control period where no clusters receive the intervention
Intervention Implementation
Sequential implementation of the AWV Practice Redesign Toolkit across clusters
Follow-up
Participants are monitored for the completion of preventive health services and AWV utilization
Treatment Details
Interventions
- Medicare AWV Practice Redesign Toolkit
Medicare AWV Practice Redesign Toolkit is already approved in United States for the following indications:
- Preventive health services
- Health risk assessment
- Personalized prevention plan
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
DARTNet
Collaborator
American Academy of Family Physicians National Research Network
Collaborator